A digital healthcare company that provides substance use disorder treatment through a private, fully digital platform.

Affect Therapeutics

Affect Therapeutics is a nation-wide substance use disorder treatment provider for alcohol, marijuana/cannabis, methamphetamine, cocaine, and prescription stimulants. Our wholistic program is delivered through a revolutionary smartphone app that reduces known barriers in access to care and leverages the latest research and technology to achieve incredible results. 

We use contingency management and other types of rewards systems as engagement techniques as well as harm reduction to keep people working towards their goals. Designed with behavioral engineering and gamification principles, our app stimulates the brain's rewards center as people reduce their use of substances and learn to manage the chronic disease of addiction into remission. 

Accredited by CARF Internation and supported by NIDA and NIH, Affect's revolutionary program and technology achieve outcomes more than double of traditional rehab models. Thousands of people who have struggled to break free of addiction have found success with us. 

We partner with a wide range of organizations who are working to address the nation's addiction crisis. We work with referral partners across the treatment sector to provide the appropriate levels of care for each individual. Affect makes care available to communities that do not have access to clinics and it works in a continuum of care so people leaving detox and inpatient can continue to work their recovery programs conveniently and discreetly. Community organizations and partners in the criminal justice system rely on us to support them. 

Find out more about how Affect works, how you can work with us, and if it can work for you at our website. Our app is free to download and use. The program is covered by Medicaid and we accept many commercial insurance plans. 

We beat the deadly game of addiction by changing the rules. Win your life back with Affect. 

Kapor Capital

City Light Capital

Acumen America

AlleyCorp

What If Ventures

Artis Ventures (AV)

LifeArc Ventures

Samsung NEXT

Rumi said, “When setting out on a journey do not seek advice from someone who never left home.” Affect is built with technology, but fueled by empathy of people who know the recovery journey. Come find your home with us and we'll take that journey together. 

#recovery #sobriety #substanceusedisorders #addictiontreatment #addiction #mentalhealth #alcohol

Miranda Bergman, one of our counselors, shares her "why" she does what she does to help people find their hope to take each step on their journey to lasting sobriety. If you've lost hope, or know someone who has, come to us and we'll get you back in touch with it. 

Affect's app delivers a full outpatient treatment program right to your phone. Our results are in the top 1% of all treatment providers. Powered by technology and fueled by empathy - we understand the science of addiction and we understand you. 

Let's get better. JoinAffect.com


#recoveryjourney #addiction #addictiontreatment #alcohol #alcoholism #mentalhealth #substanceusedisorder

Happy #pride month. We're proud of all of our members of all genders who take the journey to a better life through lasting recovery. There's no greater #love.

We’re #hiring a new Substance Use Disorder (SUD) Counselor - Telehealth Addiction Care in New Mexico. Apply today or share this post with your network.

Over 100,000 Americans died of drug overdoses in 2022, according to data from the Centers for Disease Control and Prevention. https://bit.ly/3JdsTVk

May 7 is National Fentanyl Awareness Day. Get the facts on this deadly synthetic opioid and share them widely to help educate everyone on what to do to help save lives. 

#opioids #substanceusedisorders #fentanyl #drugcrisis #awareness #addictiontreatment

https://lnkd.in/eiFvgpUJ

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 13, 2024 2:43 PM	2b217759
public peers	general	Jul 12, 2024 12:01 AM	f9ddf86e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 12, 2024 2:42 PM	5d93f35c
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	a4fee123
crunchbase profile	general
li profile	general	Jul 12, 2024 12:01 AM	f59c992a
translate crunchbase fundingrounds	general
peers	general	Jul 12, 2024 12:01 AM	6e8b6df8
news basic	general	Jul 12, 2024 12:01 AM	e7089c0a
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AFFECTTHERAPEUTICS

Affect Therapeutics